Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacy A Castner

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biological Psychiatry|March 2, 2010
Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023Stacy A Castner, Jeffrey L Arriza, John C Roberts, et al.
Neuroreport|February 27, 2010
Glycine transporter inhibition reverses ketamine-induced working memory deficitsBrooke M Roberts, Christopher L Shaffer, Patricia A Seymour, et al.
Biological Psychiatry|October 23, 2010
Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptorsStacy A Castner, Gennady N Smagin, Timothy M Piser, et al.
Drug Discovery Today|May 23, 2009
Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophreniaJohn H Krystal, David F Tolin, Gerard Sanacora, et al.
Behavioural Brain Research|March 30, 2010
Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunctionBrooke M Roberts, Daniel E Holden, Christopher L Shaffer, et al.
Psychopharmacology|March 24, 2023
Effects of DPTQ, a novel positive allosteric modulator of the dopamine D1 receptor, on spontaneous eye blink rate and spatial working memory in the nonhuman primateStacy A Castner, Linli Zhang, Charles R Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2013
Awake nonhuman primate brain PET imaging with minimal head restraint: evaluation of GABAA-benzodiazepine binding with 11C-flumazenil in awake and anesthetized animalsChristine M Sandiego, Xiao Jin, Tim Mulnix, et al.
Nature Aging|July 3, 2023
Longevity factor klotho enhances cognition in aged nonhuman primatesStacy A Castner, Shweta Gupta, Dan Wang, et al.
Frontiers in Pharmacology|August 1, 2020
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic ActivationRouba Kozak, Tamás Kiss, Keith Dlugolenski, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 8, 2014
Reduction of brain kynurenic acid improves cognitive functionRouba Kozak, Brian M Campbell, Christine A Strick, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biological Psychiatry|March 2, 2010
Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023Stacy A Castner, Jeffrey L Arriza, John C Roberts, et al.
Neuroreport|February 27, 2010
Glycine transporter inhibition reverses ketamine-induced working memory deficitsBrooke M Roberts, Christopher L Shaffer, Patricia A Seymour, et al.
Biological Psychiatry|October 23, 2010
Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptorsStacy A Castner, Gennady N Smagin, Timothy M Piser, et al.
Drug Discovery Today|May 23, 2009
Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophreniaJohn H Krystal, David F Tolin, Gerard Sanacora, et al.
Behavioural Brain Research|March 30, 2010
Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunctionBrooke M Roberts, Daniel E Holden, Christopher L Shaffer, et al.
Psychopharmacology|March 24, 2023
Effects of DPTQ, a novel positive allosteric modulator of the dopamine D1 receptor, on spontaneous eye blink rate and spatial working memory in the nonhuman primateStacy A Castner, Linli Zhang, Charles R Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2013
Awake nonhuman primate brain PET imaging with minimal head restraint: evaluation of GABAA-benzodiazepine binding with 11C-flumazenil in awake and anesthetized animalsChristine M Sandiego, Xiao Jin, Tim Mulnix, et al.
Nature Aging|July 3, 2023
Longevity factor klotho enhances cognition in aged nonhuman primatesStacy A Castner, Shweta Gupta, Dan Wang, et al.
Frontiers in Pharmacology|August 1, 2020
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic ActivationRouba Kozak, Tamás Kiss, Keith Dlugolenski, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 8, 2014
Reduction of brain kynurenic acid improves cognitive functionRouba Kozak, Brian M Campbell, Christine A Strick, et al.
Pageof 2